NEW YORK (GenomeWeb News) – Stat-Diagnostica today announced that it has raised €17 million ($22.1 million) in a Series B financing round.

The Barcelona, Spain-based firm said that it will use the funds to complete development of its Near Patient Testing diagnostic system and to clinically validate its first products. The test platform combines molecular and immunoassay techniques in a single device and can provide results in less than 30 minutes, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: map of human protein interactions, mutant phenotype variability in organisms of the same species from different genetic backgrounds, and more.

Critics call the Fred Hutchinson Cancer Research Center's Gary Gilliland's prediction of cancer cures within 10 years "out of touch with reality" and "irresponsible."

Ivan Oransky discusses the need for reproducibility research at The Conversation.

The San Diego Union-Tribune posts videos from Biocom's Speaker Series with Illumina's Jay Flatley, who discusses Roche's failed hostile takeover bid.